The company recorded revenues of $3.3 million during the fiscal year ended December 2006, a decrease of 61.4% over 2005. The operating loss of the company was $24.3 ...

The company recorded revenues of $27.4 million during the fiscal year ended December 2006, as compared to $5.1 million in fiscal 2005. The operating loss of the company was ...

The company recorded revenues of $14 million during the fiscal year ended December 2006, a decrease of 17% over 2005. The operating loss of the company was $34 ...

The company recorded revenues of $56 million during the fiscal year ended December 2006, an increase of 24.4% over 2005. The operating loss of the company was $11 million ...

The company recorded revenues of $167.2 million during the fiscal year ended December 2006, an increase of 26.3% over 2005. The operating profit of the company was $98.8 million ...

The company recorded revenues of $375.6 million during the fiscal year ended December 2006, as compared to $174.1 million in the fiscal year 2005. The operating loss of the ...

The company recorded revenues of $2,132.5 million during the fiscal year ended June 2007, an increase of 9.4% over 2006. The operating profit of the company was $173.1 million ...

The company recorded revenues of $1,611.8 million during the fiscal year ended March 2007, an increase of 28.2% over 2006. The operating profit of the company was $427.6 million ...

The company recorded revenues of $1,739.2 million during the fiscal year ended December 2006, an increase of 4.9% over 2005. The operating profit of the company was $203.7 million ...

The company recorded revenues of $1,276.8 million during the fiscal year ended December 2006; an increase of 2.6% over 2005. The operating loss of the company was $8.5 million ...

The company recorded revenues of $18.9 million during the fiscal year ended December 2006, an increase of 35.6% over 2005. The operating loss of the company was $109.3 million ...

The company recorded revenues of $194.7 million during the fiscal year ended December 2006, an increase of 61.4% over 2005. The operating profit of the company was $4.9 million ...

Third Wave Technologies (Third Wave) develops and markets molecular diagnostics for a variety of DNA and RNA analysis applications. The company primarily operates in the US and Japan. It ...

Altana is engaged in developing, manufacturing and marketing of specialized range of chemical products. The group primarily operates in Europe and North America. It is headquartered in Bad Homburg, ...

Biogen Idec is engaged in the development, manufacturing, and commercialization of novel therapies in the areas of oncology, neurology and immunology. The company's key products include Avonex and Rituxan. ...

Cephalon is a global biopharmaceutical company engaged in developing and marketing drugs in four therapeutic areas: central nervous system (CNS) disorders, pain, cancer and addiction. It is headquartered in ...

Genentech is a biotechnology company that discovers, develops, manufactures, and markets biotherapeutics for significant unmet medical needs. The company primarily operates in the US. It is headquartered in South ...

Genzyme Corporation (Genzyme) is a global biotechnology company. Its product and service portfolio is focused on rare disorders, renal disease, orthopaedics, organ transplant, and diagnostic and predictive testing. The ...

Invitrogen Corporation (Invitrogen) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide. The company is focused on genomics, proteomics, bioinformatics, cell ...

Medimmune is a biotechnology company, engaged in the development, manufacture and commercialization of medicines in the areas of infectious diseases, cancer and inflammatory disease. The company's major products include ...